wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q35213027-31FC5EC9-0C98-4F4D-96FD-CE026FD90A6C
Q35213027-31FC5EC9-0C98-4F4D-96FD-CE026FD90A6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35213027-31FC5EC9-0C98-4F4D-96FD-CE026FD90A6C
A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies
P2860
Q35213027-31FC5EC9-0C98-4F4D-96FD-CE026FD90A6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35213027-31FC5EC9-0C98-4F4D-96FD-CE026FD90A6C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f642b528a93a84c9590f99c1e49a752f1a0f0a0d
P2860
Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma.